Neurologic Disorders clinical trials

Explore recruiting neurologic disorders clinical trials.

Recruiting neurologic disorders studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neurologic Disorders trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A follow-up study evaluating the long term safety of autologous CD34+-enriched hematopoietic progenitor cells genetically modified with a lentiviral vector encoding for the human interferon-α2 gene previously administered to patients with glioblastoma multiforme

Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A clinical trial to evaluate the long-term safety and durability of efficacy of BI 3720931, an inhaled lentiviral vector gene therapy, after single dose administration in a previous clinical trial in people with cystic fibrosis rolled-over from a previous clinical trial with BI 3720931 (LenticlairTM-ON).

Spain, France, Italy, Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Long-Term Follow-up of Subjects With Transfusion-Dependant β-Thalassemia Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector

Germany, France, Italy, Greece

Therapeutic confirmatory (Phase III) EU CTIS Study details

Long-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Spain, Netherlands, France, Germany, Austria, Belgium +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Longterm Follow-up of Subjects with Cerebral Adrenoleukodystrophy Who Were Treated with Lenti-D Drug Product

France, Germany, Italy, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Neurologic Disorders trials by city

Neurologic Disorders in Toronto Neurologic Disorders in Vancouver Neurologic Disorders in Montreal Neurologic Disorders in Calgary Neurologic Disorders in Edmonton Neurologic Disorders in Ottawa Neurologic Disorders in Winnipeg Neurologic Disorders in Quebec City Neurologic Disorders in Hamilton Neurologic Disorders in Kitchener Neurologic Disorders in London Neurologic Disorders in Halifax Neurologic Disorders in New York Neurologic Disorders in Los Angeles Neurologic Disorders in Chicago Neurologic Disorders in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease